Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Nanoscale|December 2, 2021
Mass spectrometric detection of KRAS protein mutations using molecular imprintingRachel L Norman, Rajinder Singh, Frederick W Muskett, et al.
Chemmedchem|December 15, 2010
Structure-activity relationship refinement and further assessment of indole-3-glyoxylamides as a lead series against prion diseaseMark J Thompson, Jennifer C Louth, Steven Ferrara, et al.
Life Science Alliance|August 5, 2024
Chaperone BiP controls ER stress sensor Ire1 through interactions with its oligomersSam Dawes, Nicholas Hurst, Gabriel Grey, et al.
Thrombosis and Haemostasis|April 22, 2016
Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarctionMark R Thomas, Allison C Morton, Rashed Hossain, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
Extracellular Matrix Remodeling Alleviates Memory Deficits in Alzheimer's Disease by Enhancing the Astrocytic Autophagy-Lysosome PathwayQinghu Yang, Chengxiang Yan, Yahan Sun, et al.
European Journal of Medicinal Chemistry|July 6, 2011
Discovery of 6-substituted indole-3-glyoxylamides as lead antiprion agents with enhanced cell line activity, improved microsomal stability and low toxicityMark J Thompson, Jennifer C Louth, Steven Ferrara, et al.
Nature Chemical Biology|April 30, 2014
Plant perception of β-aminobutyric acid is mediated by an aspartyl-tRNA synthetaseEstrella Luna, Marieke van Hulten, Yuhua Zhang, et al.
Stem Cells (Dayton, Ohio)|February 28, 2012
A small molecule modulator of prion protein increases human mesenchymal stem cell lifespan, ex vivo expansion, and engraftment to bone marrow in NOD/SCID miceSindhu T Mohanty, Claire J Cairney, Andrew D Chantry, et al.
Anticancer Research|January 18, 2003
Prostate-specific antigen (PSA)-mediated proliferation, androgenic regulation and inhibitory effects of LY312340 in HOS-TE85 (TE85) human osteosarcoma cellsChristian M Gygi, Ilan Y Leibovitch, Robert Adlington, et al.
Molecular Informatics|January 23, 2024
Synthetically accessible de novo design using reaction vectors: Application to PARP1 inhibitorsGian Marco Ghiandoni, Stuart R Flanagan, Michael J Bodkin, et al.
Pageof 22